Xinghuo Li, Ph.D.

Xinghuo is a Senior Associate on the Frazier Life Sciences team focused on identifying and evaluating new investment opportunities.

Xinghuo joined the Frazier Life Sciences team in 2024 where she focuses on identifying and evaluating new investment opportunities.

Prior to joining Frazier, Xinghuo was a management consultant with McKinsey’s Life Sciences practice, where she advised pharmaceutical clients on strategy and operations in the area of R&D innovation, commercialization and business development.

Xinghuo’s graduate research at the Weill Cornell Graduate School of Medical Sciences and Memorial Sloan Kettering Cancer Center focused on the development of novel CAR-T cell therapy to improve the efficacy against multiple tumor types.

Xinghuo received her Ph.D. in Molecular Biology from Weill Cornell Graduate School of Medical Sciences and B.S. in Pharmaceuticals from Peking University.